| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.3390/IJMS20092249 |
| P953 | full work available at URL | https://www.mdpi.com/1422-0067/20/9/2249 |
| P932 | PMC publication ID | 6540058 |
| P698 | PubMed publication ID | 31067725 |
| P50 | author | Giuseppe Saglio | Q53342434 |
| Jessica Petiti | Q85535925 | ||
| Giacomo Andreani | Q89522716 | ||
| Daniela Cilloni | Q89522722 | ||
| P2093 | author name string | Daniela Cilloni | |
| Giuseppe Saglio | |||
| Carmen Fava | |||
| Valentina Rosso | |||
| Giacomo Andreani | |||
| Jessica Petiti | |||
| Matteo Dragani | |||
| P2860 | cites work | Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2 | Q24568313 |
| Evaluation of a droplet digital polymerase chain reaction format for DNA copy number quantification | Q24606577 | ||
| Digital PCR | Q24685020 | ||
| Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction | Q29618837 | ||
| A gain-of-function mutation of JAK2 in myeloproliferative disorders | Q29618851 | ||
| Measurable residual disease testing in acute myeloid leukaemia. | Q30234914 | ||
| Epigenomic changes during leukemia cell differentiation: analysis of histone acetylation and cytosine methylation using CpG island microarrays | Q33205674 | ||
| Epigenetics in normal and malignant hematopoiesis: An overview and update 2017. | Q33607609 | ||
| Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML. | Q33754603 | ||
| Genome wide analysis of acute myeloid leukemia reveal leukemia specific methylome and subtype specific hypomethylation of repeats. | Q34221312 | ||
| Comparison of four digital PCR platforms for accurate quantification of DNA copy number of a certified plasmid DNA reference material | Q34490796 | ||
| A certified plasmid reference material for the standardisation of BCR-ABL1 mRNA quantification by real-time quantitative PCR | Q35059443 | ||
| Digital quantitation of potential therapeutic target RNAs | Q36862792 | ||
| European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013. | Q37026032 | ||
| Pre- and post-transplant quantification of measurable ('minimal') residual disease via multiparameter flow cytometry in adult acute myeloid leukemia | Q37072126 | ||
| Detection and quantification of chimerism by droplet digital PCR | Q37196095 | ||
| Droplet digital polymerase chain reaction for DNMT3A and IDH1/2 mutations to improve early detection of acute myeloid leukemia relapse after allogeneic hematopoietic stem cell transplantation. | Q37216267 | ||
| Digital PCR Panel for Sensitive Hematopoietic Chimerism Quantification after Allogeneic Stem Cell Transplantation | Q37286538 | ||
| Alu methylation serves as a biomarker for non-invasive diagnosis of glioma | Q37295593 | ||
| Epigenetics of hematopoiesis and hematological malignancies | Q37343797 | ||
| Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale | Q37588786 | ||
| Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel | Q37624593 | ||
| Calibration-free assays on standard real-time PCR devices | Q37714874 | ||
| Beyond morphology: minimal residual disease detection in acute myeloid leukemia | Q37982240 | ||
| Understanding the molecular pathogenesis of acute promyelocytic leukemia | Q38218357 | ||
| Considerations for digital PCR as an accurate molecular diagnostic tool. | Q38262012 | ||
| Molecular monitoring of chronic myeloid leukemia: principles and interlaboratory standardization | Q38392702 | ||
| Emerging treatments for classical myeloproliferative neoplasms | Q39059533 | ||
| Recommendations for molecular testing in classical Ph1-neg myeloproliferative disorders-A consensus project of the Italian Society of Hematology | Q39275658 | ||
| Sensitive quantitation of minimal residual disease in chronic myeloid leukemia using nanofluidic digital polymerase chain reaction assay. | Q39588677 | ||
| Real-Time PCR and Droplet Digital PCR: two techniques for detection of the JAK2(V617F) mutation in Philadelphia-negative chronic myeloproliferative neoplasms. | Q40297835 | ||
| Quantification of the Mutant CALR Allelic Burden by Digital PCR: Application to Minimal Residual Disease Evaluation after Bone Marrow Transplantation. | Q40332775 | ||
| Sensitive and accurate quantification of JAK2 V617F mutation in chronic myeloproliferative neoplasms by droplet digital PCR. | Q40356455 | ||
| RT-qPCR and RT-Digital PCR: A Comparison of Different Platforms for the Evaluation of Residual Disease in Chronic Myeloid Leukemia | Q40428671 | ||
| Droplet Digital PCR Is a Reliable Tool for Monitoring Minimal Residual Disease in Acute Promyelocytic Leukemia. | Q40449249 | ||
| The epigenetic landscape of Alu repeats delineates the structural and functional genomic architecture of colon cancer cells. | Q40467056 | ||
| Establishment of mouse expanded potential stem cells. | Q45971232 | ||
| Prospective minimal residual disease monitoring to predict relapse of acute promyelocytic leukemia and to direct pre-emptive arsenic trioxide therapy. | Q45977750 | ||
| European LeukemiaNet criteria for failure or suboptimal response reliably identify patients with CML in early chronic phase treated with imatinib whose eventual outcome is poor. | Q46419894 | ||
| Quantification of Wilms' tumor 1 mRNA by digital polymerase chain reaction. | Q47247980 | ||
| Ultra-Sensitive Droplet Digital PCR for the Assessment of Microchimerism in Cellular Therapies. | Q47557726 | ||
| NCCN Clinical Practice Guidelines Acute myeloid leukemia | Q47565627 | ||
| WT1 gene expression: an excellent tool for monitoring minimal residual disease in 70% of acute myeloid leukaemia patients - results from a single-centre study | Q47594181 | ||
| Minimal/measurable residual disease in AML: consensus document from ELN MRD Working Party. | Q47734674 | ||
| The importance of relative mutant level for evaluating impact on outcome of KIT, FLT3 and CBL mutations in core-binding factor acute myeloid leukemia. | Q50893694 | ||
| Postinduction Minimal Residual Disease Predicts Outcome and Benefit From Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia With NPM1 Mutation: A Study by the Acute Leukemia French Association Group. | Q51215501 | ||
| dPCR: A Technology Review. | Q52574457 | ||
| Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial. | Q53063495 | ||
| Droplet Digital PCR for BCR/ABL(P210) Detecting of CML: A High Sensitive Method of the Minimal Residual Disease& Disease Progression. | Q54114473 | ||
| Chimerism monitoring after allogeneic hematopoietic stem cell transplantation using quantitative real-time PCR of biallelic insertion/deletion polymorphisms. | Q54193703 | ||
| Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European LeukemiaNet study. | Q54465378 | ||
| High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemia. | Q54611165 | ||
| Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial. | Q54979596 | ||
| Monitoring of clonal evolution of double C-KIT exon 17 mutations by Droplet Digital PCR in patients with core-binding factor acute myeloid leukemia. | Q54980069 | ||
| Digital droplet PCR-based absolute quantification of pre-transplant NPM1 mutation burden predicts relapse in acute myeloid leukemia patients | Q57133938 | ||
| A comparison of qPCR and ddPCR used for quantification of the JAK2 V617F allele burden in Ph negative MPNs | Q57174285 | ||
| Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: a single-institution experience | Q60921654 | ||
| Earlier relapse detection after allogeneic haematopoietic stem cell transplantation by chimerism assays: Digital PCR versus quantitative real-time PCR of insertion/deletion polymorphisms | Q64114726 | ||
| Long-term follow-up of minimal residual disease in leukemia patients by monitoring WT1 (Wilms tumor gene) expression levels | Q71571119 | ||
| C-kit mutations in core binding factor leukemias | Q73413358 | ||
| Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients | Q78306933 | ||
| DNA methylation changes after 5-aza-2'-deoxycytidine therapy in patients with leukemia | Q83364381 | ||
| Persistence of mutant isocitrate dehydrogenase in patients with acute myeloid leukemia in remission | Q84773113 | ||
| Essential thrombocythaemia with mutation in MPL: clinicopathological correlation and comparison with JAK2V617F-mutated and CALR-mutated genotypes | Q89206543 | ||
| Molecular monitoring in CML: how deep? How often? How should it influence therapy? | Q90029094 | ||
| Droplet digital PCR for quantification of PML-RARα in acute promyelocytic leukemia: a comprehensive comparison with real-time PCR | Q90929744 | ||
| IDH1 and IDH2 mutations in patients with acute myeloid leukemia: Suitable targets for minimal residual disease monitoring? | Q91271732 | ||
| Comprehensive clinical-molecular transplant scoring system for myelofibrosis undergoing stem cell transplantation | Q91555964 | ||
| Quantitative detection of IDH2 mutation for minimal residual disease monitoring in patients with acute myeloid leukemia and its comparison with mutations in NPM1 gene | Q95406325 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | molecular diagnostic techniques | Q69527481 |
| P304 | page(s) | 2249 | |
| P577 | publication date | 2019-01-01 | |
| 2019-05-07 | |||
| P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
| P1476 | title | Digital PCR in Myeloid Malignancies: Ready to Replace Quantitative PCR? | |
| P478 | volume | 20 |
Search more.